Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma

Background: Messenger ribonucleic acid (mRNA) vaccine has been considered as a potential therapeutic strategy and the next research hotspot, but their efficacy against prostate adenocarcinoma (PRAD) remains undefined. This study aimed to find potential antigens of PRAD for mRNA vaccine development a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yukui Gao, Guixin Wang, Yanzhuo Chen, Mingpeng Zhang, Wenlong Gao, Zhiqun Shang, Yuanjie Niu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-04-01
coleção:	Frontiers in Genetics
Assuntos:	mRNA vaccine immunotype prostate adenocarcinoma tumor immune microenvironment immune landscape
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fgene.2022.886983/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!